IBD is characterized by chronic, recurrent intestinal inflammation, with its inflammatory microenvironment filled with pro-inflammatory cytokines (IL-6, TNF-α, IL-1β) and accompanied by extensive immune cell infiltration (Onyiah and Colgan, 2016). This evidence concerns the gene IL1B and inflammatory bowel disease.